Literature DB >> 23695072

Day-hospital withdrawal for chronic migraine with medication overuse: results at 3 years follow-up.

L Grazzi1, F Andrasik, S Usai, G Bussone.   

Abstract

Patients with chronic headache and medication overuse are particularly difficult to treat, with no one approach being universally accepted. Some type of withdrawal program, however, is typically implemented before beginning a pharmacological prophylaxis treatment. Different withdrawal modalities have been performed for managing these patients: at first step, in-patient withdrawal has been confirmed effective in preceding clinical experiences. In recent years, new modalities for withdrawal have been developed as day-hospital setting. Purpose of this study was to determine the clinical course of a sample of chronic migraine patients with medication overuse 3 years after day-hospital withdrawal. A group of 202 patients were treated. Patients were suffering from chronic migraine with medication overuse according with IHS criteria. All patients were submitted to a day-hospital withdrawal and then they were followed with meetings every 3 months until the first year and then every 6 months until the last follow-up 3 years after withdrawal. Eighty patients achieved the last follow-up meeting 3 years after withdrawal. Patients clinically improved, significantly, both for days of headache per month and consumption of medications per month. From these results, the day-hospital setting for withdrawal, followed by periodic clinical meetings, seems to be effective for this category of patients to improve significantly at long-term headache frequency and analgesics intake.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23695072     DOI: 10.1007/s10072-013-1389-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  6 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

2.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

Review 3.  Behavioral facilitation of medical treatment for headache--part II: Theoretical models and behavioral strategies for improving adherence.

Authors:  Jeanetta C Rains; Donald B Penzien; Gay L Lipchik
Journal:  Headache       Date:  2006-10       Impact factor: 5.887

4.  Disability in chronic migraine with medication overuse: treatment effects through 5 years.

Authors:  F Andrasik; L Grazzi; S Usai; S Kass; G Bussone
Journal:  Cephalalgia       Date:  2010-02-15       Impact factor: 6.292

Review 5.  Medication-overuse headache: a worldwide problem.

Authors:  Hans-Christoph Diener; Volker Limmroth
Journal:  Lancet Neurol       Date:  2004-08       Impact factor: 44.182

6.  Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up.

Authors:  Licia Grazzi; Frank Andrasik; Domenico D'Amico; Susanna Usai; Steven Kass; Gennaro Bussone
Journal:  Headache       Date:  2004 Jul-Aug       Impact factor: 5.887

  6 in total
  2 in total

1.  [Classification and therapy of medication-overuse headache: impact of the third edition of the International Classification of Headache Disorders].

Authors:  H Göbel; K Heinze-Kuhn; I Petersen; C Göbel; A Göbel; A Heinze
Journal:  Schmerz       Date:  2014-04       Impact factor: 1.107

Review 2.  Update of Inpatient Treatment for Refractory Chronic Daily Headache.

Authors:  Tzu-Hsien Lai; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2016-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.